Gleevec, STI571
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
National Cancer Institute (NCI)
Overview
Gleevec, STI571 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Gleevec, STI571 clinical trials
Explore related
Medical disclaimer. This page summarizes research about Gleevec, STI571 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.